Drug Shortage Report for ACYCLOVIR SODIUM INJECTION

Last updated on 2018-10-16 History
Report ID 61472
Drug Identification Number 02236926
Brand name ACYCLOVIR SODIUM INJECTION
Common or Proper name Acyclovir Sodium Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) ACYCLOVIR
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 20mL
ATC code J05AB
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-09-17
Actual start date
Estimated end date
Actual end date 2018-10-15
Shortage status Resolved
Updated date 2018-10-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2018-10-16 English Compare
v5 2018-10-15 French Compare
v4 2018-10-15 English Compare
v3 2018-09-18 English Compare
v2 2018-09-14 French Compare
v1 2018-09-14 English Compare

Showing 1 to 6 of 6